Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma

Clinical trial NCT00090038 · COMPLETED

Trial details

NCT number: NCT00090038
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma

Start date: 2003-10-01
Primary completion: 2007-06-01
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.